Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 21;9(9):779.
doi: 10.3390/antiox9090779.

The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia

Affiliations
Review

The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia

Marzia Perluigi et al. Antioxidants (Basel). .

Abstract

Down syndrome (DS) is the most common genetic cause of intellectual disability that is associated with an increased risk to develop early-onset Alzheimer-like dementia (AD). The brain neuropathological features include alteration of redox homeostasis, mitochondrial deficits, inflammation, accumulation of both amyloid beta-peptide oligomers and senile plaques, as well as aggregated hyperphosphorylated tau protein-containing neurofibrillary tangles, among others. It is worth mentioning that some of the triplicated genes encoded are likely to cause increased oxidative stress (OS) conditions that are also associated with reduced cellular responses. Published studies from our laboratories propose that increased oxidative damage occurs early in life in DS population and contributes to age-dependent neurodegeneration. This is the result of damaged, oxidized proteins that belong to degradative systems, antioxidant defense system, neuronal trafficking. and energy metabolism. This review focuses on a key element that regulates redox homeostasis, the transcription factor Nrf2, which is negatively regulated by BACH1, encoded on chromosome 21. The role of the Nrf2/BACH1 axis in DS is under investigation, and the effects of triplicated BACH1 on the transcriptional regulation of Nrf2 are still unknown. In this review, we discuss the physiological relevance of BACH1/Nrf2 signaling in the brain and how the dysfunction of this system affects the redox homeostasis in DS neurons and how this axis may contribute to the transition of DS into DS with AD neuropathology and dementia. Further, some of the evidence collected in AD regarding the potential contribution of BACH1 to neurodegeneration in DS are also discussed.

Keywords: Alzheimer disease; BACH1; Down syndrome; Nrf2; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
BACH1/Nrf2 signaling regulates antioxidant response. Under normal conditions (left), Keap1/Nrf2 retains Nrf2 in the cytoplasm. Exposure of cells to oxidative insult leads to the release of Nrf2 from Keap1/Nrf2. Nrf2 then translocates to the nucleus and binds to MAREs as a heterodimer with small Mafs, thereby activating oxidative stress-response genes (e.g., HO-1 and NQO1), while Bach1 is displaced from MAREs and exported out of the nucleus. In trisomic cells (DS) (right), triplication of BACH1 competes with Nrf2 thus resulting in reduced binding of Nrf2 to MAREs. This event may explain the increased oxidative stress levels of DS individuals, that is likely the result of compromised induction of antioxidant response.

References

    1. Cenini G., Dowling A.-L., Beckett T.-L., Barone E., Mancuso C., Murphy M.-P., Levine H., Lott I.-T., Schmitt F.-A., Butterfield D.A., et al. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochim. Biophys. Acta. 2012;1822:130–138. doi: 10.1016/j.bbadis.2011.10.001. - DOI - PMC - PubMed
    1. Lott I.T. Neurological phenotypes for Down syndrome across the life span. Prog. Brain Res. 2012;197:101–121. - PMC - PubMed
    1. Lu J., McCarter M., Lian G., Esposito G., Capoccia E., Delli-Bovi L.C., Hecht J., Sheen V. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression. Hum. Mol. Genet. 2016;25:1714–1727. doi: 10.1093/hmg/ddw043. - DOI - PMC - PubMed
    1. Conti A., Fabbrini F., D’Agostino P., Negri R., Greco D., Genesio R., D’Armiento M., Olla C., Paladini D., Zannini M., et al. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genom. 2007;8:268. doi: 10.1186/1471-2164-8-268. - DOI - PMC - PubMed
    1. Di Domenico F., Pupo G., Tramutola A., Giorgi A., Schinina M.E., Coccia R., Head E., Butterfield D.A., Perluigi M. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: Clues for understanding the development of Alzheimer disease. Free Radic. Biol. Med. 2014;71:270–280. doi: 10.1016/j.freeradbiomed.2014.03.027. - DOI - PMC - PubMed